{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:14Z","timestamp":1790612174320,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The low FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides and polyols, LFD) t is used in patients diagnosed with Irritable Bowel Syndrome (IBS) as part of non-pharmacological treatment. This approach is also used in patients with Small Intestine Bacterial Overgrowth (SIBO) or Intestinal Methanogen Overgrowth (IMO), but research in this area is insufficient. To fill this gap, we decided to investigate the effect of a low FODMAP diet on various parameters in patients with IBS or SIBO or IMO. The primary end point of the study was to assess the effect of a low FODMAP diet on the severity of gastrointestinal symptoms in patients diagnosed with IBS or SIBO or IMO. Secondary end points included evaluation of patients\u2019 tolerability of the low FODMAP diet; assessment of potential difficulties in completing a low FODMAP diet and evaluation of the role of the dietitian in the implementation of a complete low FODMAP diet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted using an original unvalidated questionnaire completed online by adult patients diagnosed with IBS according to Rome IV Criteria and\/or SIBO\/IMO patients diagnosed with hydrogen-methane breath test, treated with a low FODMAP diet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 98 out of 118 patients who were invited to participate took part in an online survey. The participants had previously followed a low FODMAP diet. 90.7% of IBS patients reported reduction of symptoms after LFD. The greatest reduction in symptom severity before and after the LFD was found for bloating (MD -5.03,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Less than half of the patients reported diet as easy to follow and only 43,9% of patients completed LFD. 62.2% of patients were supported by a dietetitian. Patients who completed both phases of the diet were about 3.5 times more likely to improve symptoms. Those of the patients who were taking antibiotics before the diet were approximately seven times more likely to respond well to the low FODMAP diet (OR\u202f=\u202f7.10,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.028). The beneficial effect of a LFD on symptom reduction was independent of the initial diagnosis. Dividing the diet into elimination and reintroduction phases was not significantly associated with better results (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.305). However, completing the entire diet program (i.e., going through both phases: elimination and reintroduction) was significantly associated with greater improvement (OR\u202f=\u202f3.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.024). The use of probiotics during the diet did not have a significant effect on its outcome (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.529). No difference was observed between those who took them and those who did not use probiotics. Other factors (age, gender, dietary consultation, diet tolerance) \u2013 none of these factors had a significant impact on improvement after the diet \u2013 the results did not differ depending on age, gender or whether the patient had a dietary consultation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Low FODMAP diet was well tolerated and reduced reported gastrointestinal symptoms, with the greatest effect on reducing bloating. The reduction in symptoms occurred independently of the initial diagnosis. Patients who completed both phases of the diet were taking antibiotics before the diet more likely to respond well to the low FODMAP diet. The diet proved difficult to follow, and more than half of the patients sought the support of a dietitian, which confirms the importance of such support.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1725524","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:37:13Z","timestamp":1769618233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Dagmara","family":"Bogdanowska-Charkiewicz","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"G\u00f3rski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Jurkowska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"\u015aroda","sequence":"additional","affiliation":[{"name":"Klinika MajDiet","place":["D\u0105browa G\u00f3rnicza, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"\u015awidnicka-Siergiejko","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"D\u0105browski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Daniluk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/nu16030370","article-title":"The role of the FODMAP diet in IBS","volume":"16","author":"Bertin","year":"2024","journal-title":"Nutrients"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.59556\/japi.71.0353","article-title":"Dysbiosis in irritable bowel syndrome","volume":"71","author":"Abraham","year":"2023","journal-title":"J Assoc Physicians India"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e70072","DOI":"10.1111\/1750-3841.70072","article-title":"The effects of low FODMAP diet on gut microbiota regulation: a systematic review and meta-analysis","volume":"90","author":"Chu","year":"2025","journal-title":"J Food Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","article-title":"Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/17474124.2023.2223975","article-title":"Irritable bowel syndrome - controversies in diagnosis and management","volume":"17","author":"Duncanson","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0884533613485882","article-title":"Diagnosis and management of small intestinal bacterial overgrowth","volume":"28","author":"Bohm","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/nu9090940","article-title":"Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis","volume":"9","author":"Altobelli","year":"2017","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/apt.14065","article-title":"Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome","volume":"45","author":"Krogsgaard","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/nu13072460","article-title":"Effect of low FODMAPs diet on irritable bowel syndromes: a systematic review and meta-analysis of clinical trials","volume":"13","author":"Hahn","year":"2021","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy","year":"2017","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3390\/nu16223927","article-title":"Adjunct therapies to standard care for IBS and IBD patients: digestive symptoms improvement and quality of life optimization","volume":"16","author":"Traynard","year":"2024","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.20452\/pamw.16067","article-title":"Recent advances in the treatment of irritable bowel syndrome","volume":"131","author":"Bonetto","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.1097\/SGA.0000000000000530","article-title":"Health-related quality of life in irritable bowel syndrome: a systematic review and Meta-analysis","volume":"43","author":"Cassar","year":"2020","journal-title":"Gastroenterol Nurs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV","volume":"2016","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref15","volume-title":"StatPearls","author":"Nathani","year":"2025"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1053\/j.gastro.2021.12.248","article-title":"AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review","volume":"162","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"11439","DOI":"10.3748\/wjg.v21.i40.11439","article-title":"Aspects of the non-pharmacological treatment of irritable bowel syndrome","volume":"21","author":"Eriksson","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S2468-1253(24)00245-0","article-title":"Personalisation of therapy in irritable bowel syndrome: a hypothesis","volume":"9","author":"Black","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s10620-010-1276-4","article-title":"Abnormal breath testing in IBS: a meta-analysis","volume":"55","author":"Shah","year":"2010","journal-title":"Dig Dis Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/nu17071251","article-title":"Should we treat SIBO patients? Impact on quality of life and response to comprehensive treatment: a real-world clinical practice study","volume":"17","author":"Li\u00e9bana-Castillo","year":"2025","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"ref23","first-page":"C5382","article-title":"Danish national guideline: diagnosis and treatment of irritable bowel syndrome","volume":"64","author":"Krarup","year":"2017","journal-title":"Dan Med J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/ueg2.12270","article-title":"European guidelines on functional bowel disorders with diarrhoea: united European gastroenterology (UEG) and European society for neurogastroenterology and motility (ESNM) statements and recommendations","volume":"10","author":"Tornkvist","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5114\/pg.2018.78343","article-title":"Guidelines on the management of irritable bowel syndrome: in memory of professor Witold Bartnik","volume":"13","author":"Pietrzak","year":"2018","journal-title":"Prz Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: Management of Irritable Bowel Syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology clinical practice guideline for the Management of Irritable Bowel Syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","article-title":"Evidence-based clinical practice guidelines for irritable bowel syndrome 2020","volume":"56","author":"Fukudo","year":"2021","journal-title":"J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.15403\/jgld-3581","article-title":"Romanian guidelines for nonpharmacological therapy of IBS","volume":"30","author":"Dumitrascu","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5056\/jnm19041","article-title":"Second Asian consensus on irritable bowel syndrome","volume":"25","author":"Gwee","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"683191","DOI":"10.3389\/fnut.2021.683191","article-title":"A low-FODMAP diet improves the global symptoms and bowel habits of adult IBS patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Nutr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/jgh.15410","article-title":"Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: a prospective, randomized trial","volume":"36","author":"Goyal","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MD.0000000000029088","article-title":"Effects of low-FODMAP diet on irritable bowel symptoms in patients with quiescent inflammatory bowel disease: a protocol for a systematic review and meta-analysis","volume":"101","author":"Gu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/jgh.14051","article-title":"Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial","volume":"33","author":"Zahedi","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00394-015-0922-1","article-title":"Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis","volume":"55","author":"Marsh","year":"2016","journal-title":"Eur J Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12664-022-01292-x","article-title":"Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: an initiative of the Indian Neurogastroenterology and motility association","volume":"41","author":"Ghoshal","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/jgh.13693","article-title":"The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?","author":"Gibson","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/nu16071083","article-title":"Do herbal supplements and probiotics complement antibiotics and diet in the management of SIBO? A randomized clinical trial","volume":"16","author":"Redondo-Cuevas","year":"2024","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e41399","DOI":"10.2196\/41399","article-title":"The efficacy of a diet low in fermentable oligo-, di-, monosaccharides, and polyols in irritable bowel syndrome compared to its \"real-world\" effectiveness: protocol for a systematic review","volume":"12","author":"Jent","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/jcm13247531","article-title":"Efficacy of dietary interventions for irritable bowel syndrome: a systematic review and network meta-analysis","volume":"13","author":"Haghbin","year":"2024","journal-title":"J Clin Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e1343","DOI":"10.1093\/nutrit\/nuae107","article-title":"Nutritional interventions in adult patients with irritable bowel syndrome: an umbrella review of systematic reviews and Meta-analyses of randomized clinical trials","volume":"83","author":"Zeraattalab-Motlagh","year":"2025","journal-title":"Nutr Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1177\/02601060251324235","article-title":"Is there a sex difference in response to FODMAP diet group education for IBS? A clinical practice service evaluation","volume":"31","author":"Xing","year":"2025","journal-title":"Nutr Health"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2020.22532","article-title":"Diagnosis and treatment of irritable bowel syndrome: a review","volume":"325","author":"Camilleri","year":"2021","journal-title":"JAMA"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"853011","DOI":"10.3389\/fphar.2022.853011","article-title":"Low FODMAP diet and probiotics in irritable bowel syndrome: a systematic review with network meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nut.2017.07.004","article-title":"Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"45","author":"Schumann","year":"2018","journal-title":"Nutrition"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1007\/s00394-020-02473-0","article-title":"Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis","volume":"60","author":"van Lanen","year":"2021","journal-title":"Eur J Nutr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/MCO.0000000000000116","article-title":"The role of FODMAPs in irritable bowel syndrome","volume":"17","author":"Shepherd","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anpede.2024.06.005","article-title":"The low-FODMAP diet","volume":"101","author":"Lucas Zapata","year":"2024","journal-title":"An Pediatr (Engl Ed)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/microorganisms11102369","article-title":"Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications","volume":"11","author":"Napolitano","year":"2023","journal-title":"Microorganisms"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.clnu.2020.10.013","article-title":"Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics","volume":"40","author":"Staudacher","year":"2021","journal-title":"Clin Nutr"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ajcn\/nqac176","article-title":"Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis","volume":"116","author":"So","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.2015.1007951","article-title":"Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome","volume":"16","author":"Laterza","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40265-023-01871-y","article-title":"Antibiotics and probiotics for irritable bowel syndrome","volume":"83","author":"Goodoory","year":"2023","journal-title":"Drugs"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","author":"Lembo","year":"2022","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/nu12010148","article-title":"Low FODMAP diet: evidence, doubts, and hopes","volume":"12","author":"Bellini","year":"2020","journal-title":"Nutrients"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1725524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:37:15Z","timestamp":1769618235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1725524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":57,"alternative-id":["10.3389\/fnut.2026.1725524"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1725524","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1725524"}}